Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
1987 • 11,429 citations
Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer
1985 • 2,186 citations
Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer
1989 • 1,604 citations
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.
1990 • 602 citations
Significance of ipsilateral breast tumour recurrence after lumpectomy
1991 • 556 citations
Local Recurrences and Distant Metastases After Conservative Breast Cancer Treatments: Partly Independent Events
1995 • 511 citations
The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy
1994 • 482 citations
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
1992 • 466 citations
HER-2/neu amplification predicts poor survival in node-positive breast cancer.
1990 • 456 citations
The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.
1990 • 451 citations
Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy
1984 • 360 citations
Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment
1990 • 343 citations
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes
1991 • 335 citations
Follow-up study of HER-2/neu amplification in primary breast cancer.
1991 • 268 citations
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
1991 • 267 citations
Why are local recurrences after breast-conserving therapy more frequent in younger patients?
1990 • 260 citations
Ten year results of conservative surgery and irradiation for stage I and II breast cancer
1991 • 249 citations
Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
1996 • 197 citations
A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma
1986 • 142 citations
An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy
1990 • 110 citations
Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting
1993 • 102 citations
Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data.
1991 • 98 citations
Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer
1989 • 88 citations
Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure
1989 • 72 citations
Is C-ERB B-2 a predictor for recurrent disease in early stage breast cancer?
1994 • 23 citations
Cited By (0)
No citing papers found in database